Conversa Health, a virtual care and communication platform that delivers personalized, automated patient engagement, has closed USD 12 million in a Series B funding bringing the total raised to over USD 26 million, the company said.
Co-leading the round are Builders VC and Northwell Ventures, the corporate venture arm of Northwell Health, New York´s largest healthcare provider with 23 hospitals and 800 outpatient facilities. Joining the round are P5 Health Ventures, Nassau Street Ventures and UH Ventures, the venture arm of University Hospitals, a health system in Ohio with 18 hospitals. Both Northwell Health and University Hospitals are active users of Conversa´s Virtual Care and Communication Platform™, helping patients and care teams across a wide range of use cases, including COVID-19.
Conversa enables health systems to virtually engage, monitor and manage patients more effectively and efficiently than ever before–for chronic care, acute discharge, perioperative, oncology, OBGYN, prevention and wellness, and more. Conversa´s automated care platform engages patients at high frequency and scale, while triaging to higher touch/cost care venues when necessary, optimizing and improving the use of telehealth e-visits, phone calls and in-person consults. Conversa customers experience significant clinical and operational benefits, some of which include:
Conversa is a provider of automated, personalized patient engagement at scale. The Conversa Virtual Care and Communication™ platform utilizes its proprietary patient profiling and health signals engine, and an extensive library of clinically intelligent engagement programs, to help healthcare organizations effectively and efficiently risk stratify and manage patients across the care continuum. health systems, payers, employers, and pharmaceutical companies are using Conversa to develop meaningful relationships and drive better health outcomes. To learn more, visit conversahealth.com,